Larson Financial Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473 Sell
10
-311
-97% -$16K ﹤0.01% 3495
2026
Q1
$19K Buy
321
+36
+13% +$2.34K ﹤0.01% 1876
2025
Q4
$17.6K Buy
285
+258
+956% +$15.8K ﹤0.01% 1792
2025
Q3
$1.69K Sell
27
-17
-39% -$1.18K ﹤0.01% 2773
2025
Q2
$3.51K Buy
44
+24
+120% +$2.01K ﹤0.01% 2217
2025
Q1
$1.72K Buy
20
+3
+18% +$246 ﹤0.01% 2214
2024
Q4
$1.33K Buy
17
+10
+143% +$776 ﹤0.01% 1964
2024
Q3
$505 Hold
7
﹤0.01% 2126
2024
Q2
$482 Buy
+7
New +$474 ﹤0.01% 1847

Other funds holding PBH

Larson Financial Group's PBH Position: Q2 2026 in Review

Larson Financial Group reduced its Prestige Consumer Healthcare (PBH) stake by 97% in Q2 2026, selling an estimated $16K and leaving 10 shares worth $473. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

Larson Financial Group first reported a position in PBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $19K in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Larson Financial Group held 10 shares of Prestige Consumer Healthcare worth $473 as of Q2 2026.
  • Larson Financial Group sold 311 Prestige Consumer Healthcare shares in Q2 2026, an estimated $16K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3495 holding.
  • Larson Financial Group first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Larson Financial Group's Prestige Consumer Healthcare position peaked at $19K in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.